BioMarin Pharmaceutical Inc.

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing and commercialising innovative biopharmaceuticals for serious diseases and medical conditions. Established in 1997, the company has made significant strides in the field of rare diseases, particularly those affecting children. BioMarin’s mission is to transform the lives of patients through the development of novel therapies that address unmet medical needs.

The company’s portfolio includes a range of products that target genetic disorders, metabolic diseases, and other rare conditions. BioMarin is committed to research and development, investing heavily in clinical trials to ensure the efficacy and safety of its treatments. The company collaborates with various stakeholders, including healthcare professionals, patients, and regulatory bodies, to bring its therapies to market.

BioMarin operates with a strong ethical framework, prioritising patient welfare and transparency in all its operations. The company’s vision extends beyond just providing treatments; it aims to foster a supportive community for patients and their families. Through educational initiatives and support programmes, BioMarin strives to empower patients and enhance their quality of life.

With headquarters located in the United Kingdom, BioMarin is strategically positioned to serve a global market. The company continues to expand its reach, exploring new therapeutic areas and innovative solutions to meet the evolving needs of patients worldwide.

• Founded: 1997
• Focus: Rare diseases and innovative biopharmaceuticals
• Commitment: Research, development, and patient support